We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+9.08%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$233M
AUM Growth
-$185M
Cap. Flow
-$212M
Cap. Flow %
-90.7%
Top 10 Hldgs %
36.18%
Holding
61
New
18
Increased
2
Reduced
24
Closed
16

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$12.1M
2
UHS icon
Universal Health Services
UHS
+$7.71M
3
ELV icon
Elevance Health
ELV
+$7.36M
4
ZBH icon
Zimmer Biomet
ZBH
+$5.73M
5
PFE icon
Pfizer
PFE
+$4.95M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$23.8M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$10.3M
3
MDT icon
Medtronic
MDT
+$10M
4
SNN icon
Smith & Nephew
SNN
+$8.57M
5
CTLT
CATALENT, INC.
CTLT
+$8.1M

Sector Composition

Rank Sector Weight
1 Healthcare 95.2%
2 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$11.2M 4.8%
+100,000
New +$12.1M
UNH icon
2
UnitedHealth
UNH
$370B
$8.79M 3.76%
17,500
-52,500
-75% -$23.8M
MCK icon
3
McKesson
MCK
$101B
$8.7M 3.73%
35,000
-10,000
-22% -$2.2M
TMO icon
4
Thermo Fisher Scientific
TMO
$220B
$8.34M 3.57%
12,500
-2,500
-17% -$1.56M
DHR icon
5
Danaher
DHR
$144B
$8.22M 3.52%
28,200
-5,640
-17% -$1.55M
HUM icon
6
Humana
HUM
$46.2B
$8.12M 3.48%
17,500
+5,000
+40% +$2.21M
ELV icon
7
Elevance Health
ELV
$85.5B
$8.11M 3.48%
+17,500
New +$7.36M
UHS icon
8
Universal Health Services
UHS
$10.5B
$7.78M 3.33%
+60,000
New +$7.71M
LLY icon
9
Eli Lilly
LLY
$1.06T
$7.6M 3.25%
27,500
-7,500
-21% -$1.9M
AVTR icon
10
Avantor
AVTR
$9.19B
$7.58M 3.25%
180,000
-30,000
-14% -$1.18M
THC icon
11
Tenet Healthcare
THC
$21.1B
$7.35M 3.15%
90,000
+10,000
+13% +$731K
LH icon
12
Labcorp
LH
$25.9B
$7.07M 3.03%
26,190
-2,910
-10% -$720K
ABT icon
13
Abbott
ABT
$187B
$7.04M 3.02%
50,000
-20,000
-29% -$2.56M
COR icon
14
Cencora
COR
$61.2B
$6.98M 2.99%
52,500
-5,000
-9% -$615K
HCA icon
15
HCA Healthcare
HCA
$89.5B
$6.93M 2.97%
26,987
-28,013
-51% -$6.85M
BSX icon
16
Boston Scientific
BSX
$71.5B
$6.8M 2.91%
160,000
-60,000
-27% -$2.52M
BAX icon
17
Baxter International
BAX
$14.2B
$6.44M 2.76%
75,000
-40,000
-35% -$3.22M
PFE icon
18
Pfizer
PFE
$153B
$5.91M 2.53%
+100,000
New +$4.95M
CRL icon
19
Charles River Laboratories
CRL
$12.8B
$5.65M 2.42%
15,000
-5,000
-25% -$1.94M
ABBV icon
20
AbbVie
ABBV
$435B
$5.42M 2.32%
+40,000
New +$4.73M
GMED icon
21
Globus Medical
GMED
$11.2B
$5.42M 2.32%
75,000
-20,000
-21% -$1.45M
ZBH icon
22
Zimmer Biomet
ZBH
$18.4B
$5.4M 2.31%
+43,775
New +$5.73M
CVS icon
23
CVS Health
CVS
$122B
$5.16M 2.21%
+50,000
New +$4.62M
JNJ icon
24
Johnson & Johnson
JNJ
$625B
$5.13M 2.2%
30,000
-40,000
-57% -$6.55M
BDX icon
25
Becton Dickinson
BDX
$48.2B
$4.4M 1.89%
17,938
-7,687
-30% -$1.84M
1
2 3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q4 2021 Portfolio in Review

As of Q4 2021, Sivik Global Healthcare held 61 positions worth $233M, down 44% from $419M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sivik Global Healthcare withdrew a net $212M in Q4 2021, closing 16 positions and reducing 24 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 69% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in State Street SPDR S&P Biotech ETF worth $11.2M.

  • Sivik Global Healthcare's largest Q4 2021 buy was State Street SPDR S&P Biotech ETF: 100,000 shares worth $11.2M.
  • Sivik Global Healthcare added most to Humana in Q4 2021, an estimated $2.21M increase.
  • Sivik Global Healthcare's biggest Q4 2021 reduction was UnitedHealth, cutting an estimated $23.8M.
  • Sivik Global Healthcare fully exited Seagen Inc. Common Stock in Q4 2021, selling an estimated $10.3M.
  • Sivik Global Healthcare's ten largest holdings make up 36% of its $233M portfolio in Q4 2021.
  • Sivik Global Healthcare opened 18 new positions and closed 16 in Q4 2021.
  • Sivik Global Healthcare's portfolio value fell 44% quarter-over-quarter to $233M.

Based on Sivik Global Healthcare's 13F filing for Q4 2021, filed 8 Feb 2022.